Current understanding of LRRK2 in Parkinson’s disease: biochemical and structural features and inhibitor design
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current understanding of LRRK2 in Parkinson’s disease: biochemical and structural features and inhibitor design
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 4, Issue 13, Pages 1701-1713
Publisher
Future Science, LTD
Online
2012-08-28
DOI
10.4155/fmc.12.110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models
- (2012) Thomas Kramer et al. ACS Chemical Neuroscience
- Characterization of TAE684 as a potent LRRK2 kinase inhibitor
- (2012) Jinwei Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease
- (2012) Teresa Botta-Orfila et al. BRAIN RESEARCH
- Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
- (2012) Adriana Sánchez-Danés et al. EMBO Molecular Medicine
- ArfGAP1 Is a GTPase Activating Protein for LRRK2: Reciprocal Regulation of ArfGAP1 by LRRK2
- (2012) Y. Xiong et al. JOURNAL OF NEUROSCIENCE
- LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
- (2012) M. S. Moehle et al. JOURNAL OF NEUROSCIENCE
- Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway
- (2012) Youren Tong et al. Molecular Neurodegeneration
- Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity
- (2012) F. Gillardon et al. NEUROSCIENCE
- LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
- (2012) Fumitaka Kawakami et al. PLoS One
- Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
- (2012) Beomsue Kim et al. PLoS One
- LRRK2 and Human Disease: A Complicated Question or a Question of Complexes?
- (2012) P. A. Lewis et al. Science Signaling
- GTPase Activity and Neuronal Toxicity of Parkinson's Disease–Associated LRRK2 Is Regulated by ArfGAP1
- (2012) Klodjan Stafa et al. PLoS Genetics
- Kinetic, Mechanistic, and Structural Modeling Studies of Truncated Wild-Type Leucine-Rich Repeat Kinase 2 and the G2019S Mutant
- (2011) Min Liu et al. BIOCHEMISTRY
- Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease
- (2011) Won-Gi Seol BMB Reports
- LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
- (2011) Etsuro Ohta et al. FEBS LETTERS
- Mutations inLRRK2increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death
- (2011) Dario C. Angeles et al. HUMAN MUTATION
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
- (2011) Philip J. Webber et al. JOURNAL OF MOLECULAR BIOLOGY
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- Regulation of Physiologic Actions of LRRK2: Focus on Autophagy
- (2011) Andrew Ferree et al. Neurodegenerative Diseases
- Genetic mouse models for understanding LRRK2 biology, pathology and pre-clinical application
- (2011) Zhenyu Yue PARKINSONISM & RELATED DISORDERS
- Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
- (2011) Xianting Li et al. PLoS One
- Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
- (2011) David Ramonet et al. PLoS One
- LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
- (2011) Jean-Marc Taymans et al. PLoS One
- Development of a high-throughput AlphaScreen assay measuring full-length LRRK2(G2019S) kinase activity using moesin protein substrate
- (2010) Liliana Pedro et al. ANALYTICAL BIOCHEMISTRY
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
- (2010) Nicolas Dzamko et al. BIOCHEMICAL JOURNAL
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Differential Effects of Divalent Manganese and Magnesium on the Kinase Activity of Leucine-Rich Repeat Kinase 2 (LRRK2)
- (2010) Brian Lovitt et al. BIOCHEMISTRY
- Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase Activities
- (2010) Min Liu et al. BIOCHEMISTRY
- Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation
- (2010) Zdenek Berger et al. BIOCHEMISTRY
- MKK6 binds and regulates expression of Parkinson’s disease-related protein LRRK2
- (2010) Cindy H. Hsu et al. JOURNAL OF NEUROCHEMISTRY
- Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
- (2010) Christian Johannes Gloeckner et al. JOURNAL OF PROTEOME RESEARCH
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
- (2010) Mark R. Cookson NATURE REVIEWS NEUROSCIENCE
- Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
- (2010) B. Winner et al. NEUROBIOLOGY OF DISEASE
- Protein kinases: evolution of dynamic regulatory proteins
- (2010) Susan S. Taylor et al. TRENDS IN BIOCHEMICAL SCIENCES
- The phospholipase D1 pathway modulates macroautophagy
- (2010) Claudia Dall'Armi et al. Nature Communications
- Lrrk2 interaction with α-synuclein in diffuse Lewy body disease
- (2009) Hong Qing et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Leucine-rich repeat kinase 2 mutants I2020T and G2019S exhibit altered kinase inhibitor sensitivity
- (2009) Laurie J. Reichling et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
- (2009) Hong Qing et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing
- (2009) Yipeng Wang et al. HUMAN MOLECULAR GENETICS
- Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration?
- (2009) Frank Gillardon JOURNAL OF NEUROCHEMISTRY
- The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7,in vitro
- (2009) Christian Johannes Gloeckner et al. JOURNAL OF NEUROCHEMISTRY
- Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
- (2009) L. Parisiadou et al. JOURNAL OF NEUROSCIENCE
- Pharmacodynamics of 2- ethan-1-ol (GDC-0879), a Potent and Selective B-Raf Kinase Inhibitor: Understanding Relationships between Systemic Concentrations, Phosphorylated Mitogen-Activated Protein Kinase Kinase 1 Inhibition, and Efficacy
- (2009) H. Wong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity
- (2009) Han Seok Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2
- (2008) Jason P. Covy et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Kinetic Studies of Cdk5/p25 Kinase: Phosphorylation of Tau and Complex Inhibition by Two Prototype Inhibitors
- (2008) Min Liu et al. BIOCHEMISTRY
- Structure of the Roc–COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase
- (2008) Katja Gotthardt et al. EMBO JOURNAL
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
- (2008) Yuzuru Imai et al. EMBO JOURNAL
- The Roco protein family: a functional perspective
- (2008) Ignacio Marín et al. FASEB JOURNAL
- Emerging pathways in genetic Parkinson’s disease: tangles, Lewy bodies and LRRK2
- (2008) Michael J. Devine et al. FEBS Journal
- Investigation of leucine-rich repeat kinase 2
- (2008) Vasanti S. Anand et al. FEBS Journal
- The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation
- (2008) Elisa Greggio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
- (2008) Edward D. Plowey et al. JOURNAL OF NEUROCHEMISTRY
- The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2
- (2008) L. Wang et al. JOURNAL OF NEUROSCIENCE
- The Annotation of Both Human and Mouse Kinomes in UniProtKB/Swiss-Prot
- (2008) Silvia Braconi Quintaje et al. MOLECULAR & CELLULAR PROTEOMICS
- Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations
- (2008) Jason P. Covy et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started